Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure

Liver International

Volumn 34, Issue 9, 2014, Pages 1330-1339

  Koch, Alexander ^a   Zimmermann, Henning W ^a   Gassler, Nikolaus ^a   Jochum, Christoph ^b   Weiskirchen, Ralf ^a   Bruensing, Jan ^a   Buendgens, Lukas ^a   Dückers, Hanna ^a   Bruns, Tony ^c   Gerken, Guido ^b   Neumann, Ulf P ^a   Adams, David H ^d   Trautwein, Christian ^a   Canbay, Ali ^b   Tacke, Frank ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Acute liver failure; CD87; Monocytes; Organ failure; Prognosis; suPAR

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD56 ANTIGEN; LIPOPOLYSACCHARIDE; MESSENGER RNA; UROKINASE RECEPTOR; BIOLOGICAL MARKER; PLAUR PROTEIN, HUMAN;

ACUTE LIVER FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MONOCYTE; NATURAL KILLER T CELL; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; TOXIC HEPATITIS; VIRUS HEPATITIS; BLOOD; FLOW CYTOMETRY; GERMANY; IMMUNOLOGY; LIVER; NATURAL KILLER CELL;

BIOLOGICAL MARKERS; FLOW CYTOMETRY; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LIVER; LIVER FAILURE, ACUTE; MONOCYTES; POLYMERASE CHAIN REACTION; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84908227402     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12512     Document Type: Article

References (33)

1. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010; 376: 190-201.
2. Hadem J, Strassburg CP, Manns MP. Prediction of outcome and selection of the liver transplantat candidate in acute liver failure. Front Physiol 2012; 3: 340.
3. Polson J, Lee WM; American Association for the Study of Liver D. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41: 1179-97.
4. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137: 856-64, 64 e1.
5. Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012; 3: 56.
6. Bantel H, Schulze-Osthoff K. Mechanisms of cell death in acute liver failure. Front Physiol 2012; 3: 79.
7. Backes Y, van der Sluijs KF, Mackie DP, et al. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med 2012; 38: 1418-28.
8. Koch A, Voigt S, Kruschinski C, et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2011; 15: R63.
9. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 2002; 3: 932-43.
10. Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 2010; 11: 23-36.
11. Thuno M, Macho B, Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers 2009; 27: 157-72.
12. Zimmermann HW, Koch A, Seidler S, Trautwein C, Tacke F. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis. Liver Int 2011; 32: 500-9.
13. Zimmermann HW, Reuken PA, Koch A, et al. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality. J Intern Med 2013; 274: 86-100.
14. Bechmann LP, Jochum C, Kocabayoglu P, et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol 2010; 53: 639-47.
15. Zimmermann HW, Seidler S, Gassler N, et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS ONE 2011; 6: e21381.
16. Zimmermann HW, Seidler S, Nattermann J, et al. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS ONE 2010; 5: e11049.
17. Holt AP, Haughton EL, Lalor PF, et al. Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 2009; 136: 705-14.
18. Liaskou E, Zimmermann HW, Li KK, et al. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology 2013; 57: 385-98.
19. Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009; 13: R95.
20. Hadem J, Tacke F, Bruns T, et al. Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol 2012; 10: 664-9 e2.
21. Wilhelm OG, Wilhelm S, Escott GM, et al. Cellular glycosylphosphatidylinositol- specific phospholipase D regulates urokinase receptor shedding and cell surface expression. J Cell Physiol 1999; 180: 225-35.
22. Yoshida E, Tsuchiya K, Sugiki M, et al. Modulation of the receptor for urokinase-type plasminogen activator in macrophage- like U937 cells by inflammatory mediators. Inflammation 1996; 20: 319-26.
23. Haupt TH, Petersen J, Ellekilde G, et al. Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study. Crit Care 2012; 16: R130.
24. Plesner T, Behrendt N, Ploug M. Structure, function and expression on blood and bone marrow cells of the urokinase- type plasminogen activator receptor, uPAR. Stem Cells 1997; 15: 398-408.
25. Sidenius N, Sier CF, Blasi F. Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo. FEBS Lett 2000; 475: 52-6.
26. Abeles RD, Mcphail MJ, Sowter D, et al. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi)/CD16(neg) monocytes: expansion of CD14(hi)/CD16(pos) and contraction of CD14(lo)/ CD16(pos) monocytes in acute liver failure. Cytometry A 2012; 81: 823-34.
27. Antoniades CG, Quaglia A, Taams LS, et al. Source and characterization of hepatic macrophages in acetaminophen- induced acute liver failure in humans. Hepatology 2012; 56: 735-46.
28. Zhang L, Kang W, Lei Y, et al. Granulocyte colony-stimulating factor treatment ameliorates liver injury and improves survival in rats with D-galactosamine-induced acute liver failure. Toxicol Lett 2011; 204: 92-9.
29. Garg V, Garg H, Khan A, et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 2012; 142: 505-12 e1.
30. Selleri C, Montuori N, Ricci P, et al. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood 2005; 105: 2198-205.
31. Ferraris GM, Sidenius N. Urokinase plasminogen activator receptor: a functional integrator of extracellular proteolysis, cell adhesion, and signal transduction. Semin Thromb Hemost 2013; 39: 347-55.
32. Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011; 17: 952-60.
33. Manka P, Bechmann LP, Tacke F, et al. Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure. BMC Gastroenterol 2013; 13: 58.